AGP Executive Report
Last update: 3 hours agoTB Treatment: India’s Patent Office rejected a patent application for BPaL, a six-month, all-oral regimen for drug-resistant tuberculosis. Patient groups welcomed the decision, which may support wider access, though its effect on availability in Tajikistan is not yet clear. Cross-Border Care: Residents of remote Badakhshan districts in Afghanistan report shortages of clinics, specialists and medicines; some travel to Tajikistan for treatment, often at high cost. Child Health: Tajikistan, Uzbekistan and Kyrgyzstan are stepping up investment in children’s healthcare, with a focus on primary care, early diagnosis and services for rural communities. Health Funding: Tajikistan secured $84.44 million in grants from the ADB and JICA for projects covering health, social insurance and energy.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
